Wedbush Securities’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.15M | Buy |
|
|||||
2025
Q1 | $899K | Buy |
|
|||||
2024
Q4 | $1.01M | Sell |
|
|||||
2024
Q3 | $872K | Sell |
|
|||||
2024
Q2 | $1.5M | Sell |
|
|||||
2024
Q1 | $1.87M | Buy |
|
|||||
2023
Q4 | $1.65M | Sell |
|
|||||
2023
Q3 | $1.27M | Sell |
|
|||||
2023
Q2 | $1.79M | Sell |
|
|||||
2023
Q1 | $1.7M | Sell |
|
|||||
2022
Q4 | $1.69M | Buy |
|
|||||
2022
Q3 | $1.2M | Sell |
|
|||||
2022
Q2 | $1.12M | Buy |
|
|||||
2022
Q1 | $1.9M | Buy |
|
|||||
2021
Q4 | $1.96M | Sell |
|
|||||
2021
Q3 | $2M | Buy |
|
|||||
2021
Q2 | $1.54M | Buy |
|
|||||
2021
Q1 | $1.23M | Buy |
|
|||||
2020
Q4 | $1.26M | Sell |
|
|||||
2020
Q3 | $1.46M | Sell |
|
|||||
2020
Q2 | $1.5M | Buy |
|
|||||
2020
Q1 | $909K | Buy |
|
|||||
2019
Q4 | $714K | Sell |
|
|||||
2019
Q3 | $489K | Buy |
|
|||||
2019
Q2 | $466K | Buy |
|
|||||
2019
Q1 | $355K | Sell |
|
|||||
2018
Q4 | $358K | Sell |
|
|||||
2018
Q3 | $503K | Sell |
|
|||||
2018
Q2 | $336K | Buy |
|
|||||
2018
Q1 | $256K | Sell |
|
|||||
2017
Q4 | $321K | Buy |
|
|||||
2017
Q3 | $220K | Buy |
|
|||||
2017
Q2 | $307K | Buy |
|
|||||
2017
Q1 | $339K | Buy |
|
|||||
2016
Q4 | – | Sell |
|
|||||
2016
Q3 | $267K | Hold |
|
|||||
2016
Q2 | $242K | Sell |
|
|||||
2016
Q1 | $234K | Sell |
|
|||||
2015
Q4 | $324K | Hold |
|
|||||
2015
Q3 | $339K | Buy |
|
|||||
2015
Q2 | $300K | Buy |
|
|||||
2015
Q1 | $218K | Buy |
|